Construction and application of a system for rational drug use for prescriptions from internet hospitals and external prescriptions and medical insurance fund control based on a pre-review prescription system

GE Yi; WANG Xiaolan; HAN Junping; LYU Bo; GUAN Yu; XU Feng; SHI Aiming

doi:10.6039/j.issn.1001-0408.2026.05.06

您当前的位置：

首页 >

文章列表页 >

Construction and application of a system for rational drug use for prescriptions from internet hospitals and external prescriptions and medical insurance fund control based on a pre-review prescription system

更新时间：2026-03-10

- Construction and application of a system for rational drug use for prescriptions from internet hospitals and external prescriptions and medical insurance fund control based on a pre-review prescription system
- ZHONGGUO YAOFANG Vol. 37, Issue 5, Pages: 584-588(2026)
- 作者机构：
  
  苏州大学附属第二医院药学部，江苏苏州　215000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.05.06
  CLC： R952
- Received：26 September 2025，
  
  Revised：2026-01-22，
  
  Accepted：22 January 2026，
  
  Published：15 March 2026
- 稿件说明：
移动端阅览
葛意,王晓兰,韩俊萍,等.基于前置审方系统的互联网医院处方、外配处方合理用药及医保基金管控体系构建与应用 ^Δ[J].中国药房,2026,37(05):584-588.

GE Yi,WANG Xiaolan,HAN Junping,et al.Construction and application of a system for rational drug use for prescriptions from internet hospitals and external prescriptions and medical insurance fund control based on a pre-review prescription system[J].ZHONGGUO YAOFANG,2026,37(05):584-588.
葛意,王晓兰,韩俊萍,等.基于前置审方系统的互联网医院处方、外配处方合理用药及医保基金管控体系构建与应用 ^Δ[J].中国药房,2026,37(05):584-588. DOI： 10.6039/j.issn.1001-0408.2026.05.06.

GE Yi,WANG Xiaolan,HAN Junping,et al.Construction and application of a system for rational drug use for prescriptions from internet hospitals and external prescriptions and medical insurance fund control based on a pre-review prescription system[J].ZHONGGUO YAOFANG,2026,37(05):584-588. DOI： 10.6039/j.issn.1001-0408.2026.05.06.

摘要

目的

通过升级前置审方系统功能实现互联网医院处方与外配处方的前置审核以及药品（包含院内及外配药品）支付方式的审核，在保障患者用药安全的同时管控医保支出风险。

方法

整合互联网医院处方与外配处方数据接口，实现对互联网医院处方与外配处方的实时合理用药干预；增设支付方式智能审核项目，实现药品医保支付方式的精准干预。通过比较2025年1－4月（系统升级前）和2025年5－8月（系统升级后）互联网医院处方和外配处方的点评合格率及疑似违规药品金额，进行系统升级后的效果评价。

结果

前置审方系统升级后，互联网医院处方和外配处方的合格率提升了3.5%[95%置信区间（CI）为0.3%～6.7%，

＝0.037

]

；疑似药品违规金额下降至升级前的52.9%（

95%CI为31.6%～88.5%，

＝0.026），同时平均每个月环比下降29.5%（95%CI为12.2%～43.4%，

＝0.012）。此外，新增的支付方式智能审核项目促进了我院超说明书用药管理，系统升级后共收到79份有效超说明书用药备案申请并归档。

结论

前置审方系统的升级有效提升了互联网医院处方与外配处方的点评合格率及药品医保支付准确性，并强化了超说明书用药监管，实现了临床合理性与医保合规性的双重保障。

Abstract

OBJECTIVE

To ensure the safety of patients’ drug use and control the risk of medical insurance expenditure by upgrading the pre-prescription review system to conduct pre-review on prescriptions from internet hospitals and external prescriptions， as well as to review the payment methods of drugs （including in-hospital and external drug dispensing）.

METHODS

The data interfaces of prescriptions from internet hospitals and external prescriptions were integrated to achieve real-time rational drug use intervention. Additionally， an intelligent review project for payment method was added to precisely intervene in the medical insurance payment methods of drugs. The effect of the system upgrade was evaluated by comparing the qualification rates of prescriptions from internet hospitals and external prescriptions and the suspected amounts of drug violations from January to April 2025 （before the system upgrade） and May to August 2025 （after the system upgrade）.

RESULTS

After the upgrade of the pre-prescription review system， the qualification rates of prescriptions from internet hospitals and external prescriptions increased by 3.5% [95% confidence interval （CI）＝0.3%-6.7%，

＝0.037

]

； the suspected amounts of drug violations decreased to 52.9% of the pre-upgrade level （95%CI＝31.6%-88.5%，

＝0.026）， and the average monthly sequential decrease was 29.5% （95%CI＝12.2%-43.4%，

＝0.012）. Moreover， the addition of the intelligent review project for payment methods promoted the management of off-label drug use in our hospital. After the upgrade， a total of 79

filling valid applications for off-label drug use were received and archived.

CONCLUSIONS

The upgrade of the pre-prescription review system effectively improves the review qualification rates of prescriptions from internet hospitals and external prescriptions and the accuracy of medical insurance payment for drugs， and strengthens the supervision of off-label drug use， achieving dual guarantees of clinical rationality and medical insurance compliance.

关键词

Keywords

references

吴晓燕，张海霞，赵勉，等 . 基于前置审方系统的医保用药智能审核系统构建及应用 [J ] . 中华医院管理杂志， 2024 ， 40 （ 7 ）： 541 - 546 .

邱建忠，刘柯伶，陈杏光，等 . 深圳市某公立医院互联网医院处方流转模式建设实践 [J ] . 中国药业， 2025 ， 34 （ 10 ）： 40 - 43 .

董晨东，任磊，王梦媛 . 药品处方流转的国际经验及启示 [J ] . 卫生经济研究， 2025 ， 42 （ 11 ）： 45 - 48 .

王煜昊，顾钰祺，徐伟 . 我国医保基金常态化监管的实现路径研究 [J ] . 卫生经济研究， 2025 ， 42 （ 10 ）： 28 - 31，36 .

刘晓雷，刘炜，陈敏 . 某院医保药品限制支付条件管理实践与优化建议 [J ] . 中国药业， 2023 ， 32 （ 7 ）： 25 - 27 .

何琼，刘晨红 . DRG支付改革形势下的医疗服务行为持续改进 [J ] . 中国卫生质量管理， 2023 ， 30 （ 8 ）： 68 - 70，74 .

高志，韩璐璐，刘芳，等 . 处方前置审核对门急诊合理用药及超说明书用药管理的影响 [J ] . 中国药房， 2025 ， 36 （ 13 ）： 1666 - 1670 .

石秀锦，所伟，周洋，等 . 医院精细化合理用药管理实践与探索 [J ] . 中华医院管理杂志， 2020 ， 36 （ 9 ）： 761 - 764 .

赵德华，龙小庆，王继生，等 . 抗肿瘤药品的限制支付范围与说明书适用范围的差异分析 [J ] . 中国药房， 2023 ， 34 （ 5 ）： 520 - 524 .

胡晓静 . 血液系统新型抗肿瘤药药品说明书适应证、医保限定支付范围和指南推荐的差异分析 [J ] . 中国药业， 2024 ， 33 （ 11 ）： 1 - 7 .

林薇，茅鸯对，马俐丽，等 . 146家医疗机构超说明书用药管理现状调查 [J ] . 中国医院用药评价与分析， 2024 ， 24 （ 5 ）： 619 - 622，626 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of pharmacist’s responsibilities in the risk management of electronic prescription circulation

Related Author

WANG Guangping

Related Institution

Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring

⁰